SCYNEXIS (SCYX) approves 1-for-8 reverse stock split and major cut to authorized shares
Rhea-AI Filing Summary
SCYNEXIS, Inc. held a special stockholder meeting where investors approved an amendment to its certificate of incorporation to implement a reverse stock split and decrease authorized shares. Stockholders cast 44,826,378 votes for the proposal, 6,708,960 against, and 102,965 abstaining, out of 79,442,633 shares entitled to vote.
Following this approval, the Board chose a one-for-eight reverse stock split ratio, effective May 29, 2026. Every 8 issued and outstanding shares of common stock will convert into 1 share, and authorized common shares will be reduced from 150,000,000 to 18,750,000 without changing par value.
The reverse split will proportionately affect all existing shares, as well as the share counts under equity compensation plans, options, RSUs, and warrants, with corresponding increases in option and warrant exercise prices. No fractional shares will be issued; holders entitled to fractions will receive cash instead. SCYNEXIS common stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market on June 1, 2026 under the existing ticker SCYX, with a new CUSIP number 811292 309.
Positive
- None.
Negative
- None.
Insights
SCYNEXIS is consolidating its share count with a 1-for-8 reverse split and sharply reducing authorized shares.
The company’s stockholders approved a reverse stock split and a decrease in authorized common shares, and the Board set the ratio at one-for-eight. This consolidates the existing share base and materially lowers the maximum number of shares the company can issue in the future.
The move affects all outstanding shares and equity awards proportionately, preserving ownership percentages aside from minor effects from cash paid for fractional shares. Options and warrants will cover fewer shares at higher exercise prices. Trading on a split-adjusted basis begins on June 1, 2026, which is when the market will begin reflecting the new share structure.
8-K Event Classification
Key Figures
Key Terms
reverse stock split financial
equity compensation plans financial
restricted stock units financial
Nasdaq Capital Market financial
CUSIP number financial
FAQ
What reverse stock split did SCYNEXIS (SCYX) approve in this 8-K?
SCYNEXIS approved a one-for-eight (1:8) reverse stock split of its common stock. Every eight issued and outstanding shares will automatically convert into one share, while maintaining the same overall ownership percentages aside from small adjustments related to cash paid instead of fractional shares.
How did SCYNEXIS stockholders vote on the reverse stock split proposal?
SCYNEXIS stockholders approved the reverse stock split proposal with 44,826,378 votes for, 6,708,960 against, and 102,965 abstaining. There were 79,442,633 shares entitled to vote, and 51,638,303 shares were present in person or by proxy at the special meeting.
When will SCYNEXIS’s reverse stock split become effective and when will SCYX trade split-adjusted?
The reverse stock split becomes effective May 29, 2026 under a Certificate of Amendment filed in Delaware. SCYNEXIS common stock is scheduled to begin trading on the Nasdaq Capital Market on a split-adjusted basis on June 1, 2026, under the existing ticker symbol SCYX.
What happens to SCYNEXIS options, RSUs, and warrants after the reverse stock split?
The reverse split proportionately reduces the number of shares subject to stock options, restricted stock units, and warrants outstanding immediately before effectiveness. Their exercise prices for options and warrants will increase correspondingly so each award maintains the same aggregate economic value as before the split.
Does the SCYNEXIS reverse stock split change stockholders’ ownership percentages?
The reverse stock split is intended to affect all stockholders proportionately, so individual percentage ownership of common stock remains the same. Only minor differences may arise for holders receiving cash in place of fractional shares, slightly altering their exact holdings.